ARRY-502 Uses, Dosage, Side Effects and more
ARRY-502 is under investigation in clinical trial NCT01561690 (A Study of ARRY-502 in Patients With Persistent Asthma).
| Trade Name | ARRY-502 |
| Generic | ARRY-502 |
| Type | |
| Formula | C26H23Cl2NO6 |
| Weight | Average: 516.37 Monoisotopic: 515.0902429 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
